Company Description
Veradigm Inc., a healthcare technology company, provides information technology solutions to healthcare providers, payers, and biopharma markets in the United States and internationally.
The company offers solutions to healthcare providers, comprising Practice Management software, AI Patient Scheduling Software, and Electronic Statements and Payments; revenue cycle management solutions, including Revenue Cycle Services and revenue cycle management clearinghouse; electronic health records solutions, which include ePrescribe with EPCS, EHR software, Veradigm HER, and Practice Fusion HER; and Patient Engagement Platform.
It also provides solutions to network partners, which comprise API connectivity solutions, such as Veradigm Connect, Veradigm App Expo, and Diagnostic Ordering and Resulting Network; Channel Partner Program; and Veradigm ePrescribe Enterprise.
In addition, the company offers solutions to health plans and payers, comprising risk adjustment solutions, such as Health Equity Analytics, Risk Adjustment Analytics, Risk Mitigator, Comprehensive Submissions, and Utilization Analytics; quality management solutions, which include quality analytics and risk adjustment and quality management; data exchange+coding solutions, including eChart Courier, eChart Coder, and eChart Integration and Analytics; provider engagement and Veradigm Payer Insights; and Veradigm Payerpath solutions.
Further, it provides solutions to biophama, including real world data solutions, such as real world and health data sets and cardiology and metabolic registries; real world evidence and Real World Evidence Analytics Platform; therapy focused solutions, such as cardiovascular, central nervous system, metabolic, and immunology data; and Digital Health Media solutions.
The company was formerly known as Allscripts Healthcare Solutions, Inc. and changed its name to Veradigm Inc. in January 2023.
Veradigm Inc. was founded in 1986 and is headquartered in Chicago, Illinois.
| Country | United States |
| Founded | 1986 |
| Industry | Health Information Services |
| Sector | Healthcare |
| Employees | 8,000 |
| CEO | Thomas J. Langan |
Contact Details
Address: 222 Merchandise Mart Plaza, Suite 2024 Chicago, Illinois 60654 United States | |
| Phone | (312) 506-1200 |
| Website | allscripts.com |
Stock Details
| Ticker Symbol | MDRX |
| Exchange | OTCMKTS |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001124804 |
| CUSIP Number | 01988P108 |
| ISIN Number | US01988P1084 |
| Employer ID | 36-4372754 |
| SIC Code | 7373 |
Key Executives
| Name | Position |
|---|---|
| Dr. Shih-Yin Ho M.B.A., M.D. | Interim Chief Executive Officer and Director |
| P. Gregory Garrison | Executive Chairman of the Board |
| Tejal Vakharia | Senior Vice President of Marketing and Government Affairs, General Counsel and Chief Compliance Counsel |
| Thomas J. Langan | President and Chief Commercial Officer |
| Leland A. Westerfield | Interim Chief Financial Officer and Principal Financial and Accounting Officer |
| Jenny Gelinas | Vice President of Investor Relations |
| Richard Elmore | Senior Vice President of Corporate Development and Strategy |
| Lisa Hammond C.P.C. | Senior Vice President and Chief Human Resources Officer |
| John Sage | Senior Vice President of U.S. Hospitals and Health Systems Sales |
| Elliot Bryant | Senior Vice President and General Manager for Classic Client Solutions Business Unit |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jun 10, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |
| May 28, 2024 | 8-K | Current Report |
| May 16, 2024 | SC 13D | General statement of acquisition of beneficial ownership |
| May 13, 2024 | 8-A12G/A | Filing |
| May 13, 2024 | 8-K | Current Report |
| May 13, 2024 | NT 10-Q | Notification of inability to timely file Form 10-Q or 10-QSB |
| Apr 25, 2024 | 8-K | Current Report |
| Apr 25, 2024 | 25-NSE | Filing |
| Apr 10, 2024 | 8-K | Current Report |
| Apr 5, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |